Literature DB >> 17676341

Evaluating systemic prednisone therapy for proliferating haemangioma in infancy.

Jochen Rössler1, Goetz Wehl, Charlotte Marie Niemeyer.   

Abstract

In this study, we reviewed the history of 38 children with proliferating haemangiomas treated with systemic corticosteroids at our institution between 2000 and 2002. Prednisone was administered at an initial dose of 2 mg/kg per day for 2 weeks followed by a dose of 1 mg/kg per day for another 2-4 weeks and consecutive slow tapering over an additional 4-5 months. For 93% of the children, this protocol was successful in reducing the size of the haemangioma by more than 25% after 2 weeks of treatment. Side effects were moderate and reversible after cessation of therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17676341     DOI: 10.1007/s00431-007-0561-5

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  9 in total

1.  Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas, April 7-9, 2005, Bethesda, Maryland, USA.

Authors:  Ilona J Frieden; Anita N Haggstrom; Beth A Drolet; Anthony J Mancini; Sheila Fallon Friedlander; Laurence Boon; Sarah L Chamlin; Eulalia Baselga; Maria C Garzon; Amy J Nopper; Dawn H Siegel; Erin W Mathes; Deborah S Goddard; Joyce Bischoff; Paula E North; Nancy B Esterly
Journal:  Pediatr Dermatol       Date:  2005 Sep-Oct       Impact factor: 1.588

Review 2.  Which hemangiomas to treat--and how?

Authors:  I J Frieden
Journal:  Arch Dermatol       Date:  1997-12

3.  Complications of systemic corticosteroid therapy for problematic hemangioma.

Authors:  L M Boon; D M MacDonald; J B Mulliken
Journal:  Plast Reconstr Surg       Date:  1999-11       Impact factor: 4.730

4.  Management of hemangioma of infancy: review of 245 patients.

Authors:  B M Achauer; C J Chang; V M Vander Kam
Journal:  Plast Reconstr Surg       Date:  1997-04       Impact factor: 4.730

5.  Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation.

Authors:  M L Bennett; A B Fleischer; S L Chamlin; I J Frieden
Journal:  Arch Dermatol       Date:  2001-09

6.  Induced resolution of cavernous hemangiomas following prednisolone therapy.

Authors:  H A Zarem; M T Edgerton
Journal:  Plast Reconstr Surg       Date:  1967-01       Impact factor: 4.730

7.  Effects of five commonly used glucocorticoids on haemangioma in vitro.

Authors:  Q Hasan; S T Tan; B Xu; P F Davis
Journal:  Clin Exp Pharmacol Physiol       Date:  2003-03       Impact factor: 2.557

8.  Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis.

Authors:  F Blei; E L Wilson; P Mignatti; D B Rifkin
Journal:  J Cell Physiol       Date:  1993-06       Impact factor: 6.384

9.  Treatment of hemangiomas of infants with high doses of prednisone.

Authors:  N Sadan; B Wolach
Journal:  J Pediatr       Date:  1996-01       Impact factor: 4.406

  9 in total
  7 in total

1.  Hepatic haemangioma-prenatal imaging findings, complications and perinatal outcome in a case series.

Authors:  Stephanie Franchi-Abella; Gillaume Gorincour; Freddy Avni; Laurent Guibaud; Laurent Chevret; Danièle Pariente
Journal:  Pediatr Radiol       Date:  2011-09-18

2.  [Medication-based therapy of infantile hemangioma and lymphatic malformations].

Authors:  J Rössler; F Braunschweiger; T Schill
Journal:  HNO       Date:  2014-01       Impact factor: 1.284

3.  Oral propranolol for the treatment of periorbital infantile hemangioma: a preliminary report from oman.

Authors:  Beena Harikrishna; Anuradha Ganesh; Sana Al-Zuahibi; Samia Al-Jabri; Ahmed Al-Waily; Adil Al-Riyami; Faisal Al-Azri; Feraz Masoud; Abdullah Al-Mujaini
Journal:  Middle East Afr J Ophthalmol       Date:  2011-10

4.  Successful and safe treatment of hemangioma with oral propranolol in a single institution.

Authors:  Sun Hee Chung; Dong Hyuk Park; Hye Lim Jung; Jae Won Shim; Deok Soo Kim; Jung Yeon Shim; Moon Soo Park; Hong Hoe Koo
Journal:  Korean J Pediatr       Date:  2012-05-21

5.  Effectiveness and Safety of Oral Propranolol versus Other Treatments for Infantile Hemangiomas: A Meta-Analysis.

Authors:  Xiaohan Liu; Xinhua Qu; Jiawei Zheng; Ling Zhang
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

6.  Curative effect and safety of propranolol combined with prednisone in the treatment of infantile hemangiomas.

Authors:  Huanmin Lou; Guangqi Xu; Ran Huo
Journal:  Exp Ther Med       Date:  2018-04-04       Impact factor: 2.447

7.  Oral Propranolol in Infantile Hemangiomas: Analysis of Factors that Affect the Outcome.

Authors:  Arun Mohanan Ainipully; Sarath Kumar Narayanan; Arun Preeth Vazhiyodan; Prathap Somnath
Journal:  J Indian Assoc Pediatr Surg       Date:  2019 Jul-Sep
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.